{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:33:14Z","timestamp":1791495194689,"version":"4.3.4"},"reference-count":169,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pulmonary Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.pupt.2013.11.002","type":"journal-article","created":{"date-parts":[[2013,11,16]],"date-time":"2013-11-16T17:00:18Z","timestamp":1384621218000},"page":"98-108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Biofilm-dependent airway infections: A role for ambroxol?"],"prefix":"10.1016","volume":"28","author":[{"given":"M.","family":"Cataldi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Sblendorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Leo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Piazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pupt.2013.11.002_bib1","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1034\/j.1399-3003.1999.14b35.x","article-title":"Effects of drugs on mucus clearance","volume":"14","author":"Houtmeyers","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2013.11.002_bib2","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1517\/17425255.4.8.1119","article-title":"Ambroxol in the 21st century: pharmacological and clinical update","volume":"4","author":"Malerba","year":"2008","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"2","key":"10.1016\/j.pupt.2013.11.002_bib3","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nrmicro821","article-title":"Bacterial biofilms: from the natural environment to infectious diseases","volume":"2","author":"Hall-Stoodley","year":"2004","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.pupt.2013.11.002_bib4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4248\/IJOS11026","article-title":"The clinical impact of bacterial biofilms","volume":"3","author":"H\u00f8iby","year":"2011","journal-title":"Int J Oral Sci"},{"key":"10.1016\/j.pupt.2013.11.002_bib5","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.3390\/s120302519","article-title":"Quorum sensing and bacterial social interactions in biofilms","volume":"12","author":"Li","year":"2012","journal-title":"Sensors (Basel)"},{"key":"10.1016\/j.pupt.2013.11.002_bib6","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1146\/annurev.micro.54.1.49","article-title":"Biofilm formation as microbial development","volume":"54","author":"O'Toole","year":"2000","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.pupt.2013.11.002_bib7","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2174\/1574891X11308010012","article-title":"Bacterial quorum sensing inhibitors: attractive alternatives for control of infectious pathogens showing multiple drug resistance","volume":"8","author":"Bhardwaj","year":"2013","journal-title":"Recent Pat Antiinfect Drug Discov"},{"key":"10.1016\/j.pupt.2013.11.002_bib8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1146\/annurev-micro-092412-155635","article-title":"Acyl-homoserine lactone quorum sensing: from evolution to application","volume":"67","author":"Schuster","year":"2013","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.pupt.2013.11.002_bib9","doi-asserted-by":"crossref","first-page":"628","DOI":"10.4187\/aarc0492","article-title":"Bugs, biofilms, and resistance in cystic fibrosis","volume":"54","author":"Davies","year":"2009","journal-title":"Respir Care"},{"key":"10.1016\/j.pupt.2013.11.002_bib10","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.bpa.2008.05.002","article-title":"Ventilator-associated pneumonia: problems with diagnosis and therapy","volume":"22","author":"Wiener-Kronish","year":"2008","journal-title":"Best Pract Res Clin Anaesthesiol"},{"key":"10.1016\/j.pupt.2013.11.002_bib11","first-page":"15","article-title":"Prognostic differences between VAP caused by Acinetobacter baumannii and VAP caused by other microorganisms","volume":"3","author":"Di Bonito","year":"2012","journal-title":"Transl Med UniSa"},{"key":"10.1016\/j.pupt.2013.11.002_bib12","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/MCP.0b013e32835f27be","article-title":"Hospital-acquired pneumonia and ventilator-associated pneumonia: recent advances in epidemiology and management","volume":"19","author":"Barbier","year":"2013","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.pupt.2013.11.002_bib13","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1164\/ajrccm.165.7.2105078","article-title":"Ventilator-associated pneumonia","volume":"165","author":"Chastre","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2013.11.002_bib14","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/MCC.0b013e32834a5ae9","article-title":"Attributable mortality of ventilator-associated pneumonia","volume":"17","author":"Timsit","year":"2011","journal-title":"Curr Opin Crit Care"},{"key":"10.1016\/j.pupt.2013.11.002_bib15","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1097\/01.CCM.0000181731.53912.D9","article-title":"Clinical and economic consequences of ventilator-associated pneumonia: a systematic review","volume":"33","author":"Safdar","year":"2005","journal-title":"Crit Care Med"},{"key":"10.1016\/j.pupt.2013.11.002_bib16","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/00003246-198604000-00001","article-title":"Nosocomial pulmonary infection: possible etiologic significance of bacterial adhesion to endotracheal tubes","volume":"14","author":"Sottile","year":"1986","journal-title":"Crit Care Med"},{"issue":"3","key":"10.1016\/j.pupt.2013.11.002_bib17","doi-asserted-by":"crossref","first-page":"R93","DOI":"10.1186\/cc11357","article-title":"Implications of endotracheal tube biofilm in ventilator-associated pneumonia response: a state of concept","volume":"16","author":"Gil-Perotin","year":"2012","journal-title":"Crit Care"},{"key":"10.1016\/j.pupt.2013.11.002_bib18","first-page":"277","article-title":"Typing of Pseudomonas aeruginosa isolated from patients with VAP in an intensive care unit","volume":"32","author":"Lambiase","year":"2009","journal-title":"New Microbiol"},{"key":"10.1016\/j.pupt.2013.11.002_bib19","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1164\/ajrccm.150.6.7952612","article-title":"Ventilator-associated pneumonia by Staphylococcus aureus. Comparison of methicillin-resistant and methicillin-sensitive episodes","volume":"150","author":"Rello","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2013.11.002_bib20","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1007\/s001340051014","article-title":"Implications of endotracheal tube biofilm for ventilator-associated pneumonia","volume":"25","author":"Adair","year":"1999","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.pupt.2013.11.002_bib21","first-page":"725","article-title":"The pathogenesis of ventilator-associated pneumonia: its relevance to developing effective strategies for prevention","volume":"50","author":"Safdar","year":"2005","journal-title":"Respir Care"},{"key":"10.1016\/j.pupt.2013.11.002_bib22","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/BF01705418","article-title":"The pathogenesis of ventilator-associated pneumonia: I. Mechanisms of bacterial transcolonization and airway inoculation","volume":"21","author":"Estes","year":"1995","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.pupt.2013.11.002_bib23","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/ALN.0b013e31819868e0","article-title":"Ventilator-associated pneumonia or endotracheal tube-associated pneumonia? An approach to the pathogenesis and preventive strategies emphasizing the importance of endotracheal tube","volume":"110","author":"Pneumatikos","year":"2009","journal-title":"Anesthesiology"},{"key":"10.1016\/j.pupt.2013.11.002_bib24","first-page":"774","article-title":"The ventilator circuit and ventilator-associated pneumonia","volume":"50","author":"Branson","year":"2005","journal-title":"Respir Care"},{"key":"10.1016\/j.pupt.2013.11.002_bib25","first-page":"758","article-title":"AARC clinical practice guidelines. Endotracheal suctioning of mechanically ventilated patients with artificial airways 2010","volume":"55","author":"Restrepo","year":"2010","journal-title":"Respir Care"},{"key":"10.1016\/j.pupt.2013.11.002_bib26","doi-asserted-by":"crossref","first-page":"990","DOI":"10.4187\/respcare.02380","article-title":"Ventilator associated pneumonia: evolving definitions and preventive strategies","volume":"58","author":"Mietto","year":"2013","journal-title":"Respir Care"},{"key":"10.1016\/j.pupt.2013.11.002_bib27","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10156-008-0691-3","article-title":"Pathogenesis and clinical manifestations of chronic colonization by Pseudomonas aeruginosa and its biofilms in the airway tract","volume":"15","author":"Kobayashi","year":"2009","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.pupt.2013.11.002_bib28","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.pupt.2007.12.001","article-title":"Pseudomonas aeruginosa biofilm formation in the cystic fibrosis airway","volume":"21","author":"Moreau-Marquis","year":"2008","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.pupt.2013.11.002_bib29","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1016\/S0140-6736(09)60327-5","article-title":"Cystic fibrosis","volume":"373","author":"O'Sullivan","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.pupt.2013.11.002_bib30","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0140-6736(03)12567-6","article-title":"Cystic fibrosis","volume":"361","author":"Ratjen","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.pupt.2013.11.002_bib31","doi-asserted-by":"crossref","first-page":"618","DOI":"10.4187\/aarc0443","article-title":"Pulmonary complications of cystic fibrosis","volume":"54","author":"Flume","year":"2009","journal-title":"Respir Care"},{"key":"10.1016\/j.pupt.2013.11.002_bib32","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1128\/CMR.15.2.194-222.2002","article-title":"Lung infections associated with cystic fibrosis","volume":"15","author":"Lyczak","year":"2002","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.pupt.2013.11.002_bib33","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/35037627","article-title":"Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms","volume":"407","author":"Singh","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.pupt.2013.11.002_bib34","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s12016-008-8079-9","article-title":"P.\u00a0aeruginosa biofilms in CF Infection","volume":"35","author":"Wagner","year":"2008","journal-title":"Clinic Rev Allergy Immunol"},{"key":"10.1016\/j.pupt.2013.11.002_bib35","doi-asserted-by":"crossref","first-page":"595","DOI":"10.4187\/aarc0427","article-title":"Cystic fibrosis: pathogenesis and future treatment strategies","volume":"54","author":"Ratjen","year":"2009","journal-title":"Respir Care"},{"key":"10.1016\/j.pupt.2013.11.002_bib36","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1183\/09031936.03.00057003","article-title":"New concepts of the pathogenesis of cystic fibrosis lung disease","volume":"23","author":"Boucher","year":"2004","journal-title":"Eur Respir J"},{"issue":"Suppl.\u00a05","key":"10.1016\/j.pupt.2013.11.002_bib37","doi-asserted-by":"crossref","first-page":"121S","DOI":"10.1378\/chest.121.5_suppl.121S","article-title":"COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity","volume":"121","author":"Mannino","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2013.11.002_bib38","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0140-6736(07)61377-4","article-title":"International variation in the prevalence of COPD (the BOLD study): a population-based prevalence study","volume":"370","author":"Buist","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.pupt.2013.11.002_bib39","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lozano","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.pupt.2013.11.002_bib40","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1164\/rccm.200703-417OC","article-title":"Airway bacterial concentrations and exacerbations of chronic obstructive pulmonary disease","volume":"176","author":"Sethi","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2013.11.002_bib41","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/01.mcp.0000208451.50231.8f","article-title":"Role of nontypeable Haemophilus influenzae in exacerbations and progression of chronic obstructive pulmonary disease","volume":"12","author":"Eldika","year":"2006","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.pupt.2013.11.002_bib42","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S0140-6736(11)60988-4","article-title":"New insights into the immunology of chronic obstructive pulmonary disease","volume":"378","author":"Brusselle","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.pupt.2013.11.002_bib43","doi-asserted-by":"crossref","first-page":"413735","DOI":"10.1155\/2013\/413735","article-title":"Inflammation and immune response in COPD: where do we stand?","volume":"2013","author":"Rovina","year":"2013","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.pupt.2013.11.002_bib44","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1136\/thoraxjnl-2013-203878","article-title":"Regulatory T cells and COPD","volume":"68","author":"Dancer","year":"2013","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2013.11.002_bib45","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1177\/039463201102400420","article-title":"Modulation of biofilm of strains isolated from patients with chronic obstructive pulmonary disease by levofloxacin, moxifloxacin, ciprofloxacin, amoxicillin\/clavulanic acid and ceftriaxone","volume":"24","author":"Drago","year":"2011","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.pupt.2013.11.002_bib46","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2180-2-7","article-title":"Biofilm formation by nontypeable Haemophilus influenzae: strain variability, outer membrane antigen expression and role of pili","volume":"2","author":"Murphy","year":"2002","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.pupt.2013.11.002_bib47","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ijantimicag.2007.06.029","article-title":"Activity of moxifloxacin on biofilms produced in\u00a0vitro by bacterial pathogens involved in acute exacerbations of chronic bronchitis","volume":"30","author":"Roveta","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.pupt.2013.11.002_bib48","series-title":"Abstract of the 53rd interscience conference on antimicrobial agents and chemotherapy","article-title":"Relationship between antibiotic susceptibility to \u03b2-lactams (BL), clarithromycin (CLR), and fluoroquinolones (FQ) of Streptococcus pneumoniae (Sp) isolated from COPD patients and the ability to produce mature biofilm in an in\u00a0vitro model","author":"Vandevelde","year":"2013"},{"key":"10.1016\/j.pupt.2013.11.002_bib49","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.femsim.2004.12.008","article-title":"Expression of a peroxiredoxin-glutaredoxin by Haemophilus influenzae in biofilms and during human respiratory tract infection","volume":"44","author":"Murphy","year":"2005","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.pupt.2013.11.002_bib50","doi-asserted-by":"crossref","first-page":"4959","DOI":"10.1128\/IAI.00664-08","article-title":"Diminished ICAM-1 expression and impaired pulmonary clearance of nontypeable Haemophilus influenzae in a mouse model of chronic obstructive pulmonary disease\/emphysema","volume":"76","author":"Pang","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/j.pupt.2013.11.002_bib51","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1128\/CMR.14.2.336-363.2001","article-title":"Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review","volume":"14","author":"Sethi","year":"2001","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.pupt.2013.11.002_bib52","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1056\/NEJMoa012561","article-title":"New strains of bacteria and exacerbations of chronic obstructive pulmonary disease","volume":"347","author":"Sethi","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pupt.2013.11.002_bib53","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1086\/593186","article-title":"Chronic Pseudomonas aeruginosa infection in chronic obstructive pulmonary disease","volume":"47","author":"Mart\u00ednez-Solano","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.pupt.2013.11.002_bib54","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.molimm.2012.09.011","article-title":"Mechanisms of immune dysfunction and bacterial persistence in non-cystic fibrosis bronchiectasis","volume":"55","author":"Chalmers","year":"2013","journal-title":"Mol Immunol"},{"key":"10.1016\/j.pupt.2013.11.002_bib55","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1378\/chest.10-1758","article-title":"Factors associated with bronchiectasis in patients with COPD","volume":"140","author":"Mart\u00ednez-Garc\u00eda","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2013.11.002_bib56","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1164\/rccm.201208-1518OC","article-title":"Prognostic value of bronchiectasis in patients with moderate-to-severe chronic obstructive pulmonary disease","volume":"187","author":"Mart\u00ednez-Garc\u00eda","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2013.11.002_bib57","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1164\/rccm.201303-0411CI","article-title":"Non-cystic fibrosis bronchiectasis","volume":"188","author":"McShane","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2013.11.002_bib58","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1164\/rccm.201302-0203ED","article-title":"Bronchiectasis with chronic obstructive pulmonary disease: association or a further phenotype?","volume":"187","author":"Stockley","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2013.11.002_bib59","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1469-0691.2010.03307.x","article-title":"Mycobacterium avium ssp. hominissuis biofilm is composed of distinct phenotypes and influenced by the presence of antimicrobials","volume":"17","author":"McNabe","year":"2011","journal-title":"Clin Microbiol Infect"},{"issue":"11","key":"10.1016\/j.pupt.2013.11.002_bib60","doi-asserted-by":"crossref","first-page":"e1000","DOI":"10.1016\/j.ijid.2013.03.018","article-title":"Non-tuberculous mycobacterial disease is common in patients with non-cystic fibrosis bronchiectasis","volume":"17","author":"Mirsaeidi","year":"2013","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.pupt.2013.11.002_bib61","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0966-842X(00)01913-2","article-title":"Mechanisms of biofilm resistance to antimicrobial agents","volume":"9","author":"Mah","year":"2001","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.pupt.2013.11.002_bib62","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ijantimicag.2009.12.011","article-title":"Antibiotic resistance of bacterial biofilms","volume":"35","author":"H\u00f8iby","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.pupt.2013.11.002_bib63","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1046\/j.1462-5822.2004.00367.x","article-title":"Polysaccharide intercellular adhesin (PIA) protects Staphylococcus epidermidis against major components of the human innate immune system","volume":"6","author":"Vuong","year":"2004","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.pupt.2013.11.002_bib64","doi-asserted-by":"crossref","first-page":"4329","DOI":"10.4049\/jimmunol.171.8.4329","article-title":"Compromised host defense on Pseudomonas aeruginosa biofilms: characterization of neutrophil and biofilm interactions","volume":"171","author":"Jesaitis","year":"2003","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.pupt.2013.11.002_bib65","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1128\/IAI.54.1.13-20.1986","article-title":"Interference with granulocyte function by Staphylococcus epidermidis slime","volume":"54","author":"Johnson","year":"1986","journal-title":"Infect Immun"},{"key":"10.1016\/j.pupt.2013.11.002_bib66","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1093\/infdis\/jis607","article-title":"Candida albicans biofilms do not trigger reactive oxygen species and evade neutrophil killing","volume":"206","author":"Xie","year":"2012","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.pupt.2013.11.002_bib67","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/(SICI)1097-0290(19980720)59:2<156::AID-BIT3>3.0.CO;2-G","article-title":"Resistance of biofilms to the catalase inhibitor 3-amino-1,2,4-triazole","volume":"59","author":"Lu","year":"1998","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.pupt.2013.11.002_bib68","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.1128\/IAI.00230-06","article-title":"Comparative antibody-mediated phagocytosis of Staphylococcus epidermidis cells grown in a biofilm or in the planktonic state","volume":"74","author":"Cerca","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.pupt.2013.11.002_bib69","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1086\/528992","article-title":"Biofilm formation induces C3a release and protects Staphylococcus epidermidis from IgG and complement deposition and from neutrophil-dependent killing","volume":"197","author":"Kristian","year":"2008","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.pupt.2013.11.002_bib70","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00134-009-1660-8","article-title":"Non-adherence to guidelines: an avoidable cause of failure of empirical antimicrobial therapy in the presence of difficult-to-treat bacteria","volume":"36","author":"Garcin","year":"2010","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.pupt.2013.11.002_bib71","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1186\/2047-783X-16-7-315","article-title":"Guideline-adherent initial intravenous antibiotic therapy for hospital-acquired\/ventilator-associated pneumonia is clinically superior, saves lives and is cheaper than non guideline adherent therapy","volume":"16","author":"Wilke","year":"2011","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.pupt.2013.11.002_bib72","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1164\/rccm.200802-239OC","article-title":"Persistent infection with Pseudomonas aeruginosa in ventilator-associated pneumonia","volume":"178","author":"El Solh","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2013.11.002_bib73","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1086\/591062","article-title":"Practice recommendation of Society for Healthcare Epidemiology of America\/Infectious Diseases Society of America (SHEA\/IDSA): strategies to prevent ventilator-associated pneumonia in acute care hospitals","volume":"29","author":"Cof\ufb01n","year":"2008","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.pupt.2013.11.002_bib74","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/jac\/dkn162","article-title":"Guidelines for the management of hospital-acquired pneumonia in the UK: report of the working party on hospital-acquired pneumonia of the British Society for Antimicrobial Chemotherapy","volume":"62","author":"Masterton","year":"2008","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.pupt.2013.11.002_bib75","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jcrc.2007.11.014","article-title":"Comprehensive evidence-based clinical practice guidelines for ventilator-associated pneumonia: prevention","volume":"23","author":"Muscedere","year":"2008","journal-title":"J\u00a0Crit Care"},{"key":"10.1016\/j.pupt.2013.11.002_bib76","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00134-008-1336-9","article-title":"Defining, treating and preventing hospital acquired pneumonia: European perspective","volume":"35","author":"Torres","year":"2009","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.pupt.2013.11.002_bib77","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0004-9514(09)70044-3","article-title":"Instillation of normal saline before suctioning reduces the incidence of pneumonia in intubated and ventilated adults","volume":"55","author":"Reeve","year":"2009","journal-title":"Aust J Physiother"},{"key":"10.1016\/j.pupt.2013.11.002_bib78","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1164\/rccm.201207-1160OE","article-title":"Cystic fibrosis pulmonary guidelines. Chronic medications for maintenance of lung health","volume":"187","author":"Mogayzel","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.pupt.2013.11.002_bib79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00284-008-9142-8","article-title":"Effects of ambroxol on alginate of mature Pseudomonas aeruginosa biofilms","volume":"57","author":"Li","year":"2008","journal-title":"Curr Microbiol"},{"key":"10.1016\/j.pupt.2013.11.002_bib80","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1159\/000067473","article-title":"Inhibitory effect of N-acetylcysteine on adherence of Streptococcus pneumoniae and Haemophilus influenzae to human oropharyngeal epithelial cells in\u00a0vitro","volume":"67","author":"Riise","year":"2000","journal-title":"Respiration"},{"key":"10.1016\/j.pupt.2013.11.002_bib81","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s12010-008-8312-2","article-title":"Activity of some mucolytics against bacterial adherence to mammalian cells","volume":"158","author":"Hafez","year":"2009","journal-title":"Appl Biochem Biotechnol"},{"key":"10.1016\/j.pupt.2013.11.002_bib82","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1006\/mpat.2000.0417","article-title":"Modulating effects of mucoregulating drugs on the attachment of Haemophilus influenzae","volume":"30","author":"Ndour","year":"2001","journal-title":"Microb Pathog"},{"key":"10.1016\/j.pupt.2013.11.002_bib83","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ijantimicag.2010.05.007","article-title":"Ambroxol interferes with Pseudomonas aeruginosa quorum sensing","volume":"36","author":"Lu","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.pupt.2013.11.002_bib84","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1567-1364.2012.00792.x","article-title":"Ambroxol influences voriconazole resistance of Candida parapsilosis biofilm","volume":"12","author":"Pulcrano","year":"2012","journal-title":"FEMS Yeast Res"},{"key":"10.1016\/j.pupt.2013.11.002_bib85","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/bdd.2510160504","article-title":"Evaluation of the effects of ambroxol on the ofloxacin concentrations in bronchial tissues in COPD patients with infectious exacerbation","volume":"16","author":"Paganin","year":"1995","journal-title":"Biopharm Drug Dispos"},{"key":"10.1016\/j.pupt.2013.11.002_bib86","first-page":"967","article-title":"Influence of ambroxol on amoxicillin levels in bronchoalveolar lavage fluid","volume":"37","author":"Gen\u00e9","year":"1987","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.pupt.2013.11.002_bib87","first-page":"965","article-title":"Influence of ambroxol on lung tissue penetration of amoxicillin","volume":"37","author":"Spatola","year":"1987","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.pupt.2013.11.002_bib88","first-page":"974","article-title":"Influence of ambroxol on the bronchopulmonary level of antibiotics","volume":"31","author":"Wiemeyer","year":"1981","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.pupt.2013.11.002_bib89","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000323622","article-title":"Effect of ambroxol on pneumonia caused by Pseudomonas aeruginosa with biofilm formation in an endotracheal intubation rat model","volume":"57","author":"Li","year":"2011","journal-title":"Chemotherapy"},{"key":"10.1016\/j.pupt.2013.11.002_bib90","doi-asserted-by":"crossref","first-page":"405","DOI":"10.5114\/aoms.2011.23403","article-title":"The protective effects of ambroxol in Pseudomonas aeruginosa-induced pneumonia in rats","volume":"7","author":"Gao","year":"2011","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.pupt.2013.11.002_bib91","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1378\/chest.116.1.195","article-title":"An in\u00a0vitro comparison of the mucoactive properties of guaifenesin, iodinated glycerol, surfactant, and albuterol","volume":"116","author":"Rubin","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2013.11.002_bib92","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/j.2042-7158.1991.tb03191.x","article-title":"Ambroxol inhibits Na+ absorption by canine airway epithelial cells in culture","volume":"43","author":"Tamaoki","year":"1991","journal-title":"J\u00a0Pharm Pharmacol"},{"key":"10.1016\/j.pupt.2013.11.002_bib93","first-page":"31","article-title":"Electrophysiological investigation of the effects of ambroxol on the transepithelial Na+ ion transport pathway in airways","volume":"50","author":"Tyrakowski","year":"1998","journal-title":"Pol J Pharmacol"},{"key":"10.1016\/j.pupt.2013.11.002_bib94","first-page":"53","article-title":"Ambroxol effect on transepithelial electrical potential difference of isolated tracheal wall","volume":"49","author":"Tyrakowski","year":"1997","journal-title":"Pol J Pharmacol"},{"issue":"1","key":"10.1016\/j.pupt.2013.11.002_bib95","doi-asserted-by":"crossref","first-page":"C2","DOI":"10.1152\/ajpcell.00417.2002","article-title":"Role of airway surface liquid and submucosal glands in cystic fibrosis lung disease","volume":"284","author":"Verkman","year":"2003","journal-title":"Am J Physiol Cell Physiol"},{"issue":"24","key":"10.1016\/j.pupt.2013.11.002_bib96","doi-asserted-by":"crossref","first-page":"14114","DOI":"10.1073\/pnas.231273398","article-title":"Aquaporin 5-deficient mouse lungs are hyperresponsive to cholinergic stimulation","volume":"98","author":"Krane","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pupt.2013.11.002_bib97","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cyto.2008.12.018","article-title":"Altered regulation of aquaporin gene expression in allergen and IL-13-induced mouse models of asthma","volume":"46","author":"Krane","year":"2009","journal-title":"Cytokine"},{"key":"10.1016\/j.pupt.2013.11.002_bib98","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMoa043891","article-title":"Mucus clearance and lung function in cystic fibrosis with hypertonic saline","volume":"354","author":"Donaldson","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pupt.2013.11.002_bib99","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1039\/B810471A","article-title":"Assessment of the CFTR and ENaC association","volume":"5","author":"Berdiev","year":"2009","journal-title":"Mol Biosyst"},{"key":"10.1016\/j.pupt.2013.11.002_bib100","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.bbrc.2006.03.009","article-title":"Ambroxol-induced modification of ion transport in human airway Calu-3 epithelia","volume":"343","author":"Hasegawa","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pupt.2013.11.002_bib101","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/ng1192-240","article-title":"Submucosal glands are the predominant site of CFTR expression in the human bronchus","volume":"2","author":"Engelhardt","year":"1992","journal-title":"Nat Genet"},{"key":"10.1016\/j.pupt.2013.11.002_bib102","doi-asserted-by":"crossref","DOI":"10.1002\/cbin.10146","article-title":"Effect of ambroxol on chloride transport, CFTR and ENaC in cystic fibrosis airway epithelial cells","author":"Varelogianni","year":"2013","journal-title":"Cell Biol Int"},{"key":"10.1016\/j.pupt.2013.11.002_bib103","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.resp.2007.12.007","article-title":"Upregulation of AQP3 and AQP5 induced by dexamethasone and ambroxol in A549 cells","volume":"161","author":"Ben","year":"2008","journal-title":"Respir Physiol Neurobiol"},{"key":"10.1016\/j.pupt.2013.11.002_bib104","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.resp.2011.12.008","article-title":"Anti-asthmatic agents alleviate pulmonary edema by upregulating AQP1 and AQP5 expression in the lungs of mice with OVA-induced asthma","volume":"181","author":"Dong","year":"2012","journal-title":"Respir Physiol Neurobiol"},{"key":"10.1016\/j.pupt.2013.11.002_bib105","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1128\/IAI.00645-12","article-title":"Biofilm-infected intracerebroventricular shunts elicit inflammation within the central nervous system","volume":"80","author":"Snowden","year":"2012","journal-title":"Infect Immun"},{"key":"10.1016\/j.pupt.2013.11.002_bib106","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-61779-120-8_1","article-title":"Introduction to section I: overview of approaches to study cystic fibrosis pathophysiology","volume":"742","author":"Clunes","year":"2011","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.pupt.2013.11.002_bib107","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00134-003-2001-y","article-title":"Inhibition of inflammatory responses by ambroxol, a mucolytic agent, in a murine model of acute lung injury induced by lipopolysaccharide","volume":"30","author":"Su","year":"2004","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.pupt.2013.11.002_bib108","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1006\/pupt.1999.0219","article-title":"N-acetylcysteine and ambroxol inhibit endotoxin-induced phagocyte accumulation in rat lungs","volume":"12","author":"Nawrocka","year":"1999","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.pupt.2013.11.002_bib109","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/BF01997619","article-title":"Ambroxol inhibits interleukin 1 and tumor necrosis factor production in human mononuclear cells","volume":"31","author":"Bianchi","year":"1990","journal-title":"Agents Actions"},{"key":"10.1016\/j.pupt.2013.11.002_bib110","first-page":"129","article-title":"Reduction of cytokine release of blood and bronchoalveolar mononuclear cells by ambroxol","volume":"24","author":"Pfeifer","year":"1997","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.pupt.2013.11.002_bib111","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/BF02028285","article-title":"Effect of ambroxol on neutrophil chemotaxis in\u00a0vitro","volume":"24","author":"Stokley","year":"1988","journal-title":"Agents Actions"},{"key":"10.1016\/j.pupt.2013.11.002_bib112","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0952-0600(92)90018-C","article-title":"Lung injury induced by paraquat, hyperoxia and cobalt chloride: effects of ambroxol","volume":"5","author":"Nemery","year":"1992","journal-title":"Pulm Pharmacol"},{"key":"10.1016\/j.pupt.2013.11.002_bib113","first-page":"181","article-title":"The effect of ambroxol on bleomycin-induced changes in phospholipid composition of rat lung surfactant","volume":"83","author":"Stettner","year":"1995","journal-title":"Acta Physiol Hung"},{"key":"10.1016\/j.pupt.2013.11.002_bib114","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1124\/jpet.300.2.629","article-title":"Depressant effect of ambroxol on stimulated functional responses and cell death in rat alveolar macrophages exposed to silica in\u00a0vitro","volume":"300","author":"Kim","year":"2002","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.pupt.2013.11.002_bib115","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1007\/BF00736800","article-title":"Protection against acute paraquat toxicity by ambroxol","volume":"5","author":"Perin","year":"1991","journal-title":"Cytotechnology"},{"key":"10.1016\/j.pupt.2013.11.002_bib116","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.2169\/internalmedicine.50.5407","article-title":"Protective effect of ambroxol against paraquat-induced pulmonary fibrosis in rats","volume":"50","author":"Zhi","year":"2011","journal-title":"Intern Med"},{"key":"10.1016\/j.pupt.2013.11.002_bib117","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s12032-009-9271-3","article-title":"The protective effects of ambroxol on radiation lung injury and influence on production of transforming growth factor beta1 and tumor necrosis factor alpha","volume":"27","author":"Xia","year":"2010","journal-title":"Med Oncol"},{"key":"10.1016\/j.pupt.2013.11.002_bib118","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1056\/NEJM200005043421806","article-title":"The acute respiratory distress syndrome","volume":"342","author":"Ware","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pupt.2013.11.002_bib119","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1183\/09031936.02.00229202","article-title":"Mechanisms and markers of airway inflammation in cystic fibrosis","volume":"19","author":"De Rose","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2013.11.002_bib120","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1016\/S0021-9258(19)69613-4","article-title":"Myeloperoxidase-catalyzed inactivation of alpha 1-protease inhibitor by human neutrophils","volume":"256","author":"Clark","year":"1981","journal-title":"Biol Chem J"},{"key":"10.1016\/j.pupt.2013.11.002_bib121","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1172\/JCI112523","article-title":"Oxidative regulation of neutrophil elastase-alpha-1-proteinase inhibitor interactions","volume":"77","author":"Ossanna","year":"1986","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.pupt.2013.11.002_bib122","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/0024-3205(96)00431-6","article-title":"The antioxidative activity of the mucoregulatory agents: ambroxol, bromhexine and N-acetyl-L-cysteine. A pulse radiolysis study","volume":"59","author":"Felix","year":"1996","journal-title":"Life Sci"},{"key":"10.1016\/j.pupt.2013.11.002_bib123","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/PL00007570","article-title":"Antioxidant function of ambroxol in mononuclear and polymorphonuclear cellsin\u00a0vitro","volume":"175","author":"Gillissen","year":"1997","journal-title":"Lung"},{"key":"10.1016\/j.pupt.2013.11.002_bib124","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s004330050049","article-title":"Oxidant scavenger function of ambroxol in\u00a0vitro: a comparison with N-acetylcysteine","volume":"196","author":"Gillissen","year":"1997","journal-title":"Res Exp Med"},{"key":"10.1016\/j.pupt.2013.11.002_bib125","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0954-6111(98)90506-6","article-title":"Characterization of N-acetylcysteine and ambroxol in anti-oxidant therapy","volume":"92","author":"Gillissen","year":"1998","journal-title":"Respir Med"},{"key":"10.1016\/j.pupt.2013.11.002_bib126","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000139225","article-title":"Ambroxol is a scavenger of hypochlorous acid and monochloramine","volume":"49","author":"Lapenna","year":"1994","journal-title":"Pharmacology"},{"key":"10.1016\/j.pupt.2013.11.002_bib127","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1183\/09031936.94.07091629","article-title":"Protective effect of ambroxol against heat- and hydrogen peroxide-induced damage to lung lipids in mice","volume":"7","author":"Nowak","year":"1994","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2013.11.002_bib128","first-page":"111","article-title":"Protective action of ambroxol on the oxidative damage of lipid, hyaluronic acid and collagen","volume":"6","author":"Koh","year":"1998","journal-title":"J\u00a0Appl Pharmacol"},{"key":"10.1016\/j.pupt.2013.11.002_bib129","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0014-2999(99)00585-3","article-title":"The inhibitory effect of ambroxol on hypochlorous acid-induced tissue damage and respiratory burst of phagocytic cells","volume":"383","author":"Cho","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pupt.2013.11.002_bib130","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/sj.bjp.0705497","article-title":"In\u00a0vitro inhibition of human neutrophil histotoxicity by ambroxol: evidence for a multistep mechanism","volume":"140","author":"Ottonello","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pupt.2013.11.002_bib131","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s000110050421","article-title":"Ambroxol inhibits the release of histamine, leukotrienes and cytokines from human leukocytes and mast cells","volume":"48","author":"Gibbs","year":"1999","journal-title":"Inflamm Res"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.pupt.2013.11.002_bib132","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1007\/PL00000162","article-title":"Ambroxol inhibits IgE-dependent mediator secretion from human skin mast cells","volume":"49","author":"Gibbs","year":"2000","journal-title":"Inflamm Res"},{"key":"10.1016\/j.pupt.2013.11.002_bib133","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1600-0773.1999.tb00878.x","article-title":"The inhibitory effect of ambroxol on respiratory burst, degranulation and cytosolic Ca2+ change in degraded immunoglobulin G-activated neutrophils","volume":"84","author":"Park","year":"1999","journal-title":"Pharmacol Toxicol"},{"key":"10.1016\/j.pupt.2013.11.002_bib134","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1034\/j.1600-0773.2002.910309.x","article-title":"Ambroxol inhibits peroxynitrite-induced damage of alpha1-antiproteinase and free radical production in activated phagocytic cells","volume":"91","author":"Lee","year":"2002","journal-title":"Pharmacol Toxicol"},{"key":"10.1016\/j.pupt.2013.11.002_bib135","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0014-2999(00)00739-1","article-title":"Ambroxol as an inhibitor of nitric oxide-dependent activation of soluble guanylate cyclase","volume":"407","author":"Severina","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pupt.2013.11.002_bib136","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ejphar.2005.12.057","article-title":"Reactive nitrogen species in the respiratory tract","volume":"533","author":"Ricciardolo","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pupt.2013.11.002_bib137","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0891-5849(03)00278-8","article-title":"Oxidative and nitrosative events in asthma","volume":"35","author":"Andreadis","year":"2003","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.pupt.2013.11.002_bib138","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s11882-003-0024-7","article-title":"Nitric oxide, nitrotyrosine, and nitric oxide modulators in asthma and chronic obstructive pulmonary disease","volume":"3","author":"Kharitonov","year":"2003","journal-title":"Curr Allergy Asthma Rep"},{"issue":"Suppl.\u00a06","key":"10.1016\/j.pupt.2013.11.002_bib139","doi-asserted-by":"crossref","first-page":"314S","DOI":"10.1378\/chest.122.6_suppl.314S","article-title":"Oxidant-antioxidant balance in acute lung injury","volume":"122","author":"Lang","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2013.11.002_bib140","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/jbt.20348","article-title":"Nitric oxide in paraquat-mediated toxicity: a review","volume":"24","author":"Mor\u00e1n","year":"2010","journal-title":"J\u00a0Biochem Mol Toxicol"},{"key":"10.1016\/j.pupt.2013.11.002_bib141","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.jaci.2005.06.034","article-title":"Nitrosative stress in the bronchial mucosa of severe chronic obstructive pulmonary disease","volume":"116","author":"Ricciardolo","year":"2005","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.pupt.2013.11.002_bib142","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S1095-6433(01)00324-5","article-title":"Surfactant in respiratory distress syndrome and lung injury","volume":"129","author":"Hallman","year":"2001","journal-title":"Comp Biochem Physiol A Mol Integr Physiol"},{"key":"10.1016\/j.pupt.2013.11.002_bib143","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/PL00007561","article-title":"Toxic oxidant species and their impact on the pulmonary surfactant system","volume":"175","author":"Putman","year":"1997","journal-title":"Lung"},{"key":"10.1016\/j.pupt.2013.11.002_bib144","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1385\/CBB:43:1:167","article-title":"Oxidative stress in pathogenesis of chronic obstructive pulmonary disease: cellular and molecular mechanisms","volume":"43","author":"Rahman","year":"2005","journal-title":"Cell Biochem Biophys"},{"key":"10.1016\/j.pupt.2013.11.002_bib145","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1159\/000192830","article-title":"Morphometric evaluation of ultrastructural changes in type II alveolar cells of rat lung produced by bromhexine","volume":"28","author":"Gil","year":"1971","journal-title":"Respiration"},{"key":"10.1016\/j.pupt.2013.11.002_bib146","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1159\/000194035","article-title":"Effects of metabolite VIII of bromexine (Na-872) on type II epithelium of the lung: an experimental and morphological study with reference to surfactant secretion","volume":"37","author":"Cerutti","year":"1979","journal-title":"Respiration"},{"key":"10.1016\/j.pupt.2013.11.002_bib147","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/BF00509271","article-title":"Increased incorporation of fatty acids into phospholipids of lungs and livers of rabbits under the influence of bromhexine and ambroxol","volume":"297","author":"von Wichert","year":"1977","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.pupt.2013.11.002_bib148","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1055\/s-2000-4452","article-title":"Effect of ambroxol on surfactant secretion and synthesis in isolated type II alveolar cells","volume":"54","author":"Wirtz","year":"2000","journal-title":"Pneumologie"},{"key":"10.1016\/j.pupt.2013.11.002_bib149","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.taap.2004.07.015","article-title":"Cell-specific modulation of surfactant proteins by ambroxol treatment","volume":"203","author":"Seifart","year":"2005","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.pupt.2013.11.002_bib150","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1165\/ajrcmb.21.4.3436","article-title":"Surfactant protein-B-deficient mice are susceptible to hyperoxic lung injury","volume":"21","author":"Tokieda","year":"1999","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.pupt.2013.11.002_bib151","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1159\/000194507","article-title":"Study on the influence of NA-872 (ambroxol) and dexamethasone on the differentiation of Clara cells in albino mice","volume":"43","author":"Sepulveda","year":"1982","journal-title":"Respiration"},{"key":"10.1016\/j.pupt.2013.11.002_bib152","doi-asserted-by":"crossref","first-page":"a010306","DOI":"10.1101\/cshperspect.a010306","article-title":"Bacterial biofilms: development, dispersal, and therapeutic strategies in the dawn of the postantibiotic era","volume":"3","author":"Kostakioti","year":"2013","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.pupt.2013.11.002_bib153","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1001\/jama.300.7.805","article-title":"Silver-coated endotracheal tubes and incidence of ventilator-associated pneumonia: the NASCENT randomized trial","volume":"300","author":"Kollef","year":"2008","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.pupt.2013.11.002_bib154","first-page":"3741","article-title":"Decreased Staphylococcus aureus biofilm formation on nanomodified endotracheal tubes: a dynamic airway model","volume":"7","author":"Machado","year":"2012","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.pupt.2013.11.002_bib155","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/CCM.0b013e31822e9fe3","article-title":"A\u00a0clinical assessment of the Mucus Shaver: a device to keep the endotracheal tube free from secretions","volume":"40","author":"Berra","year":"2012","journal-title":"Crit Care Med"},{"key":"10.1016\/j.pupt.2013.11.002_bib156","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/lsm.21103","article-title":"Reduction of endotracheal tube biofilms using antimicrobial photodynamic therapy","volume":"43","author":"Biel","year":"2011","journal-title":"Lasers Surg Med"},{"key":"10.1016\/j.pupt.2013.11.002_bib157","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s12028-011-9642-4","article-title":"High-dose ambroxol reduces pulmonary complications in patients with acute cervical spinal cord injury after surgery","volume":"16","author":"Li","year":"2012","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.pupt.2013.11.002_bib158","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/FJC.0b013e31819036c7","article-title":"Protective effect of ambroxol on pulmonary function after cardiopulmonary bypass","volume":"52","author":"Ulas","year":"2008","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"key":"10.1016\/j.pupt.2013.11.002_bib159","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000195847","article-title":"Alterations of the endoalveolar surfactant after surgery with extracorporeal circulation","volume":"57","author":"Marcatili","year":"1990","journal-title":"Respiration"},{"key":"10.1016\/j.pupt.2013.11.002_bib160","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ejcts.2008.11.015","article-title":"Short-term perioperative treatment with ambroxol reduces pulmonary complications and hospital costs after pulmonary lobectomy: a randomized trial","volume":"35","author":"Refai","year":"2009","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.pupt.2013.11.002_bib161","first-page":"123","article-title":"Ambroxol for prophylaxis and treatment of bronchopulmonary complications after chest surgery","volume":"6","author":"Romanini","year":"1986","journal-title":"Int J Clin Pharmacol Res"},{"key":"10.1016\/j.pupt.2013.11.002_bib162","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF02714144","article-title":"Prevention by ambroxol of bronchopulmonary complications after upper abdominal surgery: double-blind Italian multicenter clinical study versus placebo","volume":"169","author":"Fegiz","year":"1991","journal-title":"Lung"},{"key":"10.1016\/j.pupt.2013.11.002_bib163","first-page":"934","article-title":"Results of a clinical trial with ambroxol as to postoperative therapy of bronchitis","volume":"28","author":"Kranicke","year":"1978","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.pupt.2013.11.002_bib164","first-page":"284","article-title":"The management of cystic fibrosis with carbocysteine lysine salt: single-blind comparative study with ambroxol hydrochloride","volume":"23","author":"Caramia","year":"1995","journal-title":"J\u00a0Int Med Res"},{"key":"10.1016\/j.pupt.2013.11.002_bib165","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0929-693X(98)80022-5","article-title":"Respiratory evolution of patient with mucoviscidosis treated with mucolytic agents plus domase alfa","volume":"5","author":"Derelle","year":"1998","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.pupt.2013.11.002_bib166","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/BF00441781","article-title":"A\u00a0double-blind placebo controlled trial with oral ambroxol and N-acetylcysteine for mucolytic treatment in cystic fibrosis","volume":"144","author":"Ratjen","year":"1985","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.pupt.2013.11.002_bib167","first-page":"CD007168","article-title":"Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis","volume":"1","author":"Nash","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.pupt.2013.11.002_bib168","first-page":"CD001287","article-title":"Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease","volume":"8","author":"Poole","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.pupt.2013.11.002_bib169","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.pupt.2003.08.004","article-title":"Effect of twelve-months therapy with oral ambroxol in preventing exacerbations in patients with COPD. Double-blind, randomized, multicenter, placebo-controlled study (the AMETHIST Trial)","volume":"17","author":"Malerba","year":"2004","journal-title":"Pulm Pharmacol Ther"}],"container-title":["Pulmonary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553913001909?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553913001909?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T13:54:03Z","timestamp":1647093243000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553913001909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":169,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S1094553913001909"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2013.11.002","relation":{},"ISSN":["1094-5539"],"issn-type":[{"value":"1094-5539","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biofilm-dependent airway infections: A role for ambroxol?","name":"articletitle","label":"Article Title"},{"value":"Pulmonary Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pupt.2013.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}